APA (7th ed.) Citation

M, S., EHL, L., G, C., J, J., D, B., K, A., . . . GJR, C. (2025). The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer. BJR open, 7(1), tzaf010. https://doi.org/10.1093/bjro/tzaf010

Chicago Style (17th ed.) Citation

M, Severyn, Lee EHL, Chand G, Johnson J, Bailey D, Adamson K, Goh V, Hughes DJ, and Cook GJR. "The Effects of Anti-PD-1 Therapy on Programmed Death-ligand 1 Expression and Glucose Metabolism of Normal Organs in Patients with Advanced Non-small Cell Lung Cancer." BJR Open 7, no. 1 (2025): tzaf010. https://doi.org/10.1093/bjro/tzaf010.

MLA (9th ed.) Citation

M, Severyn, et al. "The Effects of Anti-PD-1 Therapy on Programmed Death-ligand 1 Expression and Glucose Metabolism of Normal Organs in Patients with Advanced Non-small Cell Lung Cancer." BJR Open, vol. 7, no. 1, 2025, p. tzaf010, https://doi.org/10.1093/bjro/tzaf010.